Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 Diabetes
September 1st 2023Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose monitoring.
Read More
Population-Based Return on Investment of Deploying Transient Elastography
May 28th 2021Deploying vibration-controlled transient elastography/controlled attenuation parameter devices at the population level is a financially advantageous solution to address the epidemic of fatty liver disease.
Read More